Then in October, after five consecutive quarters without a single traditional IPO (Neurochem began trading on Nasdaq in September but it was already listed on the Toronto exchange), Acusphere (ACUS), Advancis (AVNC), Myogen (MYOG), CancerVax (CNVX) and Genitope (
GTOP) made their debut on Nasdaq.
Tickers featured: AMGN, ANPI, AVE, BIIB, BVF, CEPH, CJC:TSX, COMRF, CUR:TSX, CYT:TSX, DDS:TSX, DNA, GPRO, GSX,
GTOP, HMSL, IDBE, INEX, JNJ, MDZ, MRK, MYOG, NRMX, PFE, PHRM, PLI:TSX, PTI:TSX, QLT, QLTI, RHHVF, SHPGY, TLCV, VSM:TSX, WHTOF, XLX:TSX.